GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » Interest Expense

Peterlabs Holdings Bhd (XKLS:0171) Interest Expense : RM-0.8 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Peterlabs Holdings Bhd's interest expense for the three months ended in Dec. 2024 was RM -0.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was RM-0.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Peterlabs Holdings Bhd's Operating Income for the three months ended in Dec. 2024 was RM 0.6 Mil. Peterlabs Holdings Bhd's Interest Expense for the three months ended in Dec. 2024 was RM -0.2 Mil. Peterlabs Holdings Bhd's Interest Coverage for the quarter that ended in Dec. 2024 was 3.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Peterlabs Holdings Bhd Interest Expense Historical Data

The historical data trend for Peterlabs Holdings Bhd's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peterlabs Holdings Bhd Interest Expense Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.27 -0.85 -0.50 -0.76 -0.76

Peterlabs Holdings Bhd Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.18 -0.22 -0.19 -0.17

Peterlabs Holdings Bhd Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd  (XKLS:0171) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Peterlabs Holdings Bhd's Interest Expense for the three months ended in Dec. 2024 was RM-0.2 Mil. Its Operating Income for the three months ended in Dec. 2024 was RM0.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was RM0.8 Mil.

Peterlabs Holdings Bhd's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*0.631/-0.171
=3.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Peterlabs Holdings Bhd Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » Interest Expense
Comparable Companies
XKLS:5278 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506 BOM:543904
Traded in Other Exchanges
N/A
Address
Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Website
https://www.peterlabs.com.my
Peterlabs Holdings Bhd is a Malaysia-based company engaged in the manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis, and feed formulation. The operating segments of the group are Manufacturing which relates to the manufacturing of animal health and nutrition products, and Trading which relates to the trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplements, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd Headlines

No Headlines